BMT Journal News

Bone Marrow Transplantation is the official journal of EBMT, it publishes high quality, peer reviewed original research and reviews that address all aspects of basic biology and clinical use of haemopoietic cell transplantation.

The journal also covers all aspects of the research and treatment of transplant-related complications and consequences including quality of life and psychological issues. Basic research studies on topics of relevance are also covered. Visit the website - https://www.nature.com/bmt/

Top cited papers in BMT

Have you read the pick of the recent most highly cited articles?

Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre, randomized controlled trial
Yingling Zu et al 

Outcomes of allogeneic transplant in patients with DDX41 mutated myelodysplastic syndrome and acute myeloid leukemia
Anmol Baranwal et al 

Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)
Enrico Maffini et al 

Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT
Carmelo Gurnari & Donal P. McLornan 

Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myeloma
Charalampos Charalampous et al

 The abstract book of the EBMT 48th Annual Meeting was published on November 2, 2022:

Abstracts from the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)

Get your research the recognition it deserves - Submit to BMT TODAY